Ilika: Building a bridge from niche batteries to mass market demand

Ilika Plc

Ilika is moving beyond its micro-battery roots with a clear push into large-format solid-state technology. Its latest presentation laid out a deliberate plan to scale from proven IP in specialist markets to commercial relevance in electric vehicles and energy storage.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika: Building a bridge from niche batteries to mass market demand

Ilika is translating niche micro-battery expertise into a larger bet on scalable solid-state solutions for EVs and energy storage.

Ilika targets neuromodulation market with medical battery offering

Ilika is stepping directly into the medical-device market with its solid-state microbattery platform now featured at NANS 2026.

Ilika’s pack design shifts focus from cells to architecture

Ilika’s solid-state cells allowed a full battery pack redesign, cutting 100 kg, lowering cost, and extending range, without compromising safety.

Ilika CEO on Stereax production, Goliath progress, and growing market demand

Ilika's Graeme Purdy shares updates on the company’s advancements in solid-state battery technology, including Stereax manufacturing milestones, the upcoming release of Goliath P1.5 prototypes, and expanding customer interest across medical and industrial sectors.

Ilika Plc Customer Demand Soars as Stereax Production Ramps Up with Cirtec (Video)

Graeme Purdy, CEO of Ilika plc, outlines how solid-state Stereax batteries are entering production at Cirtec—with customer-ready units already on test. Applications span implanted sensors to orthodontics, and next-gen Goliath cells are primed for delivery by year-end.

Ilika reports advancing performance across Stereax and Goliath programmes

Ilika has outlined progress for the six months to 31 October 2025, including Stereax production qualification, Goliath prototype validation, and continued development supported by grant funding.

Search

Search